The Valley Desk

NCT06937099 · Interventional trial

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Overall registry status Recruiting

Phase 3

Conditions Crohn's Disease, Obesity or Overweight

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov